StockDuty ← Dashboard Aug 17, 2026 11:22 AM ET
SignalCorporate

NRX PHARMACEUTICALS GAAP EPS OF -$0.44, REVENUE OF $1.1M - SEEKINGALPHA

EPS miss and thin revenue signal financial strain, driving corporate news interest.

What changed
EPS miss and thin revenue signal financial strain, driving corporate news interest.
Why it matters
EPS miss and thin revenue signal financial strain, driving corporate news interest. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →